Exhibit 10.7 SECOND LICENSE AGREEMENT This SECOND LICENSE AGREEMENT, dated as of this 3rd day of March, 2005 (this "SECOND LICENSE AGREEMENT") is made by and between Cytomedix, Inc. ("LICENSOR") and DePuy Spine, Inc. (f/k/a DePuy AcroMed, Inc.)...Second License Agreement • March 31st, 2005 • Cytomedix Inc • Services-commercial physical & biological research • Illinois
Contract Type FiledMarch 31st, 2005 Company Industry Jurisdiction
WITNESSETH:Second License Agreement • October 30th, 1996 • Depuy Inc • Orthopedic, prosthetic & surgical appliances & supplies • Indiana
Contract Type FiledOctober 30th, 1996 Company Industry Jurisdiction
SECOND LICENSE AGREEMENT BETWEEN LEXEO THERAPEUTICS, LLC AND CORNELL UNIVERSITY FOR DOCKET NO. D-6749 DOCKET NO. D-7225 DOCKET NO. D-7605 DOCKET NO. D-9179 DOCKET NO. D-9325 DOCKET NO. D-9332 DOCKET NO. D-9472 CTL CONTRACT NO. [***]Second License Agreement • May 5th, 2022 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 5th, 2022 Company Industry JurisdictionThis Second License Agreement (this “Agreement”) is made by and between LEXEO Therapeutics, LLC, a Delaware limited liability company, having an office at 430 East 29th Street, 14th Floor, New York, NY 10016 (“LICENSEE”), and Cornell University, a New York education corporation (“Cornell”), as represented by its Cornell Center for Technology Licensing (“CTL”) at 395 Pine Tree Road, Suite 310, Ithaca, NY 14850. Cornell and LICENSEE each may be referred to herein as a “Party” and together as the “Parties.”
SECOND LICENSE AGREEMENT BETWEEN LEXEO THERAPEUTICS, LLC AND CORNELL UNIVERSITY FOR DOCKET NO. D-6749 DOCKET NO. D-7225 DOCKET NO. D-7605 DOCKET NO. D-9179 DOCKET NO. D-9325 DOCKET NO. D-9332 DOCKET NO. D-9472 CTL CONTRACT NO. [***]Second License Agreement • September 29th, 2023 • Lexeo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 29th, 2023 Company Industry JurisdictionThis Second License Agreement (this “Agreement”) is made by and between LEXEO Therapeutics, LLC, a Delaware limited liability company, having an office at 430 East 29th Street, 14th Floor, New York, NY 10016 (“LICENSEE”), and Cornell University, a New York education corporation (“Cornell”), as represented by its Cornell Center for Technology Licensing (“CTL”) at 395 Pine Tree Road, Suite 310, Ithaca, NY 14850. Cornell and LICENSEE each may be referred to herein as a “Party” and together as the “Parties.”